Price (delayed)
$10.46
Market cap
$196.79M
P/E Ratio
43.58
Dividend/share
N/A
EPS
$0.24
Enterprise value
$130.48M
brainsway is a leading global neurmodulation company with headquarters in jerusalem and the us. our patented breakthrough technology has already treated over 10,000 patients, and has helped usher in a
There are no recent dividends present for BWAY.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.